Publication: Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic
1
Issued Date
2004-11-01
Resource Type
ISSN
13602276
Other identifier(s)
2-s2.0-9644287921
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Tropical Medicine and International Health. Vol.9, No.11 (2004), 1175-1183
Suggested Citation
Jörg M. Stohrer, Sabine Dittrich, Vonthalom Thongpaseuth, Viengxay Vanisaveth, Rattanaxay Phetsouvanh, Samlane Phompida, Feliciano Monti, Eva Haria Christophel, Niklas Lindegardh, Anna Annerberg, Tomas Jelinek Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. Tropical Medicine and International Health. Vol.9, No.11 (2004), 1175-1183. doi:10.1111/j.1365-3156.2004.01320.x Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/21351
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic
Abstract
The efficacy of the six-dose regimen of artemether-lumefantrine was compared with the combination of artesunate and mefloquine in a randomised, comparative trial in Luang Namtha Province, Northern Laos. Of 1033 screened patients, 201 were positive for Plasmodium falciparum; 108 patients of all age groups (2-66 years) with acute, uncomplicated P. falciparum malaria were enrolled in the study, 100 of whom were followed-up for 42 days. Fifty-three patients received artemether-lumefantrine and 55 received artesunante- mefloquine. Both drug combinations induced rapid clearance of parasites and malaria symptoms; there was no significant difference in the initial therapeutic response parameters. Both regimes were well tolerated. After 42 days, cure rates were 93.6% (95% CI = 82.5-98.7%; 44 of 47 patients) for artemether-lumefantrine and 100% (95% CI = 93.3-100.0%; 53 of 53 patients) for artesunate-mefloquine. The results show the excellent efficacy and tolerability of both artemether-lumefantrine and artesunate-mefloquine in Northern Laos.